| RS2061032710 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061038127 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Alport syndrome |
| RS2061040474 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS2061041235 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2061066554 |
RTTN
|
Health Risk |
Pathogenic |
— |
| RS2061073406 |
HUWE1
|
Health Risk |
Likely pathogenic |
— |
| RS2061094546 |
SCN5A
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2061097129 |
ITGB4
|
Health Risk |
Likely pathogenic |
— |
| RS2061098856 |
NDUFA13
|
Health Risk |
Pathogenic |
Decreased activity of mitochondrial complex I, Mitochondrial complex I deficiency |
| RS2061100863 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2061105702 |
NDUFA13
|
Health Risk |
Pathogenic |
Decreased activity of mitochondrial complex I, Mitochondrial complex I deficiency |
| RS2061105872 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS2061111812 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS2061113374 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS2061116343 |
NFKB2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2061147191 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2061157682 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2061162295 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2061168979 |
ITGB4
|
Health Risk |
Likely pathogenic |
— |
| RS2061175467 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2061175762 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061204822 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2061224553 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS2061228286 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2061229370 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2061230986 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061265539 |
BPTF
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2061267874 |
SCN5A
|
Health Risk |
Likely pathogenic |
Cardiac arrhythmia, Brugada syndrome |
| RS2061270021 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2061271482 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061278560 |
NFKB2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2061279365 |
NFKB2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2061298344 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061301543 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2061305104 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061310130 |
COG1
|
Health Risk |
Pathogenic |
COG1 congenital disorder of glycosylation, COG1 congenital disorder of glycosylation |
| RS2061310712 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061312470 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2061316510 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2061318885 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2061323811 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061323841 |
GPHN
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS2061324917 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061326120 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061326585 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2061333185 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS2061340335 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2061340651 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2061351777 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2061353270 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061353736 |
BRIP1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2061354035 |
BRIP1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS2061355653 |
ITGB4
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS2061358219 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061359296 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061363316 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome |
| RS2061366129 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2061375797 |
COG1
|
Health Risk |
Pathogenic |
COG1 congenital disorder of glycosylation, COG1 congenital disorder of glycosylation |
| RS2061376825 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2061387927 |
GRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 3, Fraser syndrome 3 |
| RS2061391242 |
TCF4
|
Health Risk |
Pathogenic |
— |
| RS2061393783 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2061393958 |
COL4A4
|
Health Risk |
Pathogenic |
Alport syndrome, Autosomal recessive Alport syndrome |
| RS2061394463 |
IL17RA
|
Health Risk |
Pathogenic |
Immunodeficiency 51, Immunodeficiency 51 |
| RS2061396039 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive Alport syndrome, Hematuria |
| RS2061397001 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2061409627 |
CTNND1
|
Health Risk |
Pathogenic |
Cleft lip with or without cleft palate, Cleft lip with or without cleft palate |
| RS2061428442 |
ITGB4
|
Health Risk |
Likely pathogenic |
ITGB4-related disorder, ITGB4-related disorder |
| RS2061464108 |
ATP2B2
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss, Autosomal dominant nonsyndromic hearing loss |
| RS2061467212 |
SCN5A
|
Health Risk |
Likely pathogenic |
— |
| RS2061476512 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2061477443 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2061477722 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061478781 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061478980 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2061494723 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2061514243 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2061523666 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2061536765 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1E, Dilated cardiomyopathy 1E |
| RS2061536929 |
ITGB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS2061548697 |
CDAN1
|
Health Risk |
Pathogenic |
— |
| RS2061548936 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 9 |
| RS2061563475 |
GALK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061564118 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061565957 |
FTSJ1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2061566465 |
RALGAPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with hypotonia |
| RS2061574410 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061578946 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061580394 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2061581608 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2061592335 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061594762 |
GALK1
|
Health Risk |
Pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061596711 |
GALK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061598689 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061598873 |
GALK1
|
Health Risk |
Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061599016 |
GALK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061599170 |
GALK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of galactokinase, Deficiency of galactokinase |
| RS2061653217 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2061653258 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2061653458 |
H3-3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Brain imaging abnormality |